Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Total Non-Current Liabilities (2020)

Tango Therapeutics (TNGX) has 1 years of Total Non-Current Liabilities data on record, last reported at $168.6 million in Q4 2020.

  • For Q4 2020, Total Non-Current Liabilities changed N/A year-over-year to $168.6 million; the TTM value through Dec 2020 reached $168.6 million, changed N/A, while the annual FY2020 figure was $168.6 million, N/A changed from the prior year.
  • Total Non-Current Liabilities reached $168.6 million in Q4 2020 per TNGX's latest filing.
  • Across five years, Total Non-Current Liabilities topped out at $168.6 million in Q4 2020 and bottomed at $168.6 million in Q4 2020.